Risk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTE.
Simon R HellerIldiko LingvaySteven P MarsoAthena Philis-TsimikasThomas R PieberNeil R PoulterRichard E PratleyElise Hachmann-NielsenKajsa KvistMartin LangeAlan C MosesMarie Trock AndresenJohn B Busenull nullPublished in: Diabetes, obesity & metabolism (2020)
The risk score demonstrated that a high risk of severe hypoglycaemia was associated with a high incidence of MACE and all-cause mortality and that, in this high-risk group, those treated with degludec had a lower incidence of MACE. These observations support the hypothesis that hypoglycaemia is a risk factor for cardiovascular events.